Spearhead Capital Advisors’s Moderna MRNA Stock Holding History

Spearhead Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$256K	Sell
2022 Q1	$392K	Buy
2021 Q4	$389K	Buy
2021 Q3	$587K	Sell
2021 Q2	$372K	Sell
2021 Q1	$570K	Buy
2020 Q4	$441K	Sell
2020 Q3	$346K	Sell
2020 Q2	$316K	Sell
2020 Q1	$265K	Buy